Anthem Biosciences Limited · NSE:ANTHEM
Anthem Biosciences — Q2 FY2027 Earnings Presentation
12 slides from Anthem Biosciences's earnings presentation, Nov 3, 2026
Slide 1: Exchange filing cover letter for earnings presentation
Date: November 03, 2026 To, BSE Limited, National Stock Exchange of India Limited 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544449 NSE Scrip Symbol: ANTHEM Subject: Earnings Call Presentati
Slide 2: Anthem Biosciences Limited Investor Presentation
Anthem Biosciences Limited Investor Presentation November 3, 2026
Slide 3: Safe Harbour
Safe Harbour Except for the historical information contained herein, statements in this presentation and the subsequent discussions, which include words or phrases such as "will", "aim", "will likely result", "would", "believe", "may", "expect", "will continue", "anticipate", "estimate", "intend", "
Slide 4: Consolidated Profit & Loss Statement: Q2FY27 vs Q2FY26 vs Q1FY27
Consolidated Profit & Loss Statement: Q2FY27 vs Q2FY26 vs Q1FY27 Performance Particulars (₹ Mn) Q2FY27 Q2FY26 YoY Q1FY27 QoQ FY26 Revenue from Operations 5,940 5,505 7.9% 4,182 42.0% 21,293 CRDMO 5,093 4,662 9.2% 3,408 49.4% 17,775 Specialty Ingredients 848 843 0.6% 774 9.5% 3,518 Other Income 589 4
Slide 5: Q2FY27 Consolidated Financial Highlights
Q2FY27 Consolidated Financial Highlights Revenues (₹ Mn) EBITDA1 (₹ Mn) and EBITDA Margins (%age) PAT (₹ Mn) and PAT Margins (%age) 5,940 44.5% 50.6% 32.4% 5,505 29.0% 40.0% 30.0% 20.0% 10.0% 3,304 0.0% 2,661 2,115 1,734 Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27 PBT (₹ Mn) and PBT Margins (%age) Net
Slide 6: Growth accelerated in Q2FY27, yielding robust financial performance
Growth accelerated in Q2FY27, yielding robust financial performance and highest ever margins ₹5,940 Mn 50.6% 32.4% Strong Business Q2FY27 Revenues Q2FY27 EBITDA Margin Q2FY27 PAT Margin Performance 2,344 / 1,173 425KL 142KL Robust Technology # Employees / Scientific Staff Custom Synthesis Capacity F
Slide 7: Consolidated Profit & Loss Statement: H1FY27 vs H1FY26
Consolidated Profit & Loss Statement: H1FY27 vs H1FY26 Performance Particulars (₹ Mn) H1FY27 H1FY26 YoY FY26 Revenue from Operations 10,123 10,914 -7.2% 21,293 CRDMO 8,501 9,195 -7.6% 17,775 Specialty Ingredients 1,622 1,718 -5.6% 3,518 Other Income 838 699 19.9% 1,508 Total Revenues 10,960 11,613 -
Slide 8: H1FY27 Consolidated Financial Highlights
H1FY27 Consolidated Financial Highlights Revenues (₹ Mn) EBITDA2 (₹ Mn) and EBITDA Margins (%age) PAT (₹ Mn) and PAT Margins (%age) 10,914 41.4% 46.2% 10,123 26.6% 30.2% 4,805 5,059 0.0% 3,092 3,314 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 PBT (₹ Mn) and PBT Margins (%age) Net Cash (₹ Mn) Specialty
Slide 9: Financial performance remains strong for H1FY27
Financial performance continues to remain strong with robust return profile for H1FY27 ₹10,123 Mn 46.2% 30.2% Strong Business H1FY27 Revenues H1FY27 EBITDA Margin H1FY27 PAT Margin Performance 65.3% 15 + 9 8.1% Platforms across Commercial Molecules Commercial + R&D Services discovery to Contribution
Slide 10: Financial Highlights: Q2FY27 and H1FY27
Financial Highlights: Q2FY27 and H1FY27 Quarterly Performance: Consolidated Revenue from Operations was ₹5,940 Mn for the quarter CRDMO business delivered ₹5,093 Mn revenues Specialty Ingredients delivered ₹848 Mn revenues EBITDA was ₹3,304 Mn, with EBITDA margins at 50.6% PAT (Profit Afte
Slide 11: Message from Chairman, MD and CEO
Message from Chairman, MD and CEO “We are pleased to report a robust performance for Q2FY27, driven by our CRDMO revenue stream. Underlying demand continues to remains strong and we are confident in our ability to sustain growth and create long-term value for all stakeholders We expanded our EBITDA
Slide 12: Thank You
Thank You Anthem Biosciences Limited NeoAnthem Lifesciences Private Limited Unit I: No.49, F1 &F2, Canara Bank Road, Unit III: 313-P,314-P, 318-P, Harohalli Bommasandra Industrial Area Phase 1, Industrial Area, Phase II, Bommasandra, Bangalore, 560 099, India Kanakapura Taluk, Ramnagar District, Har